Key Segments:
By Product
- Analyzers
- Reagents & Consumables
By Test Type
- Clinical Laboratory Tests
- Point-of-Care Tests
By Method
- Enzyme-linked Immunosorbent Assay (ELISA)
- Latex-enhanced Immunoturbidimetric Assays
- Fluorescence Immunoassays
- Others
By Application
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Others
By End-Use
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Others
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Poland
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
The D-Dimer Testing Market is expected to grow at a CAGR of 4.59% from 2026 to 2035.
The D-Dimer Testing Market was valued at USD 2.00 Billion in 2025.
Rising venous thromboembolism prevalence and increasing adoption of point-of-care D-dimer testing are driving demand for rapid diagnosis and treatment.
Deep Vein Thrombosis dominated the D-Dimer Testing Market
North America dominated the D-Dimer Testing Market in 2025.